ARTICLE | Distillery Therapeutics
Complement component C1q as a hepatitis-associated liver cancer target
May 1, 2020 6:17 PM UTC
INDICATION: Hepatitis; liver cancer...
BCIQ Target Profiles
INDICATION: Hepatitis; liver cancer...
BCIQ Target Profiles
BCIQ Target Profiles